European Association of Nuclear Medicine Joins as Co-Organizer of 26th European Multidisciplinary Congress on Urological Cancers

Vienna, April 8, 2026 — The European Association of Nuclear Medicine (EANM) has joined as a co-organizer of the 26th European Multidisciplinary Congress on Urological Cancers (EMUC26), a leading event in the field of urological oncology. This collaboration aims to integrate advancements in nuclear medicine with multidisciplinary approaches to address urological cancers, marking a significant development in the ongoing efforts to improve patient care and outcomes.

The partnership underscores the growing role of nuclear medicine in cancer diagnosis and treatment. By aligning with EMUC26, EANM brings its expertise in molecular imaging and targeted therapies to one of Europe’s most prominent platforms for urological cancer research and clinical practice. The congress serves as a hub for specialists from various disciplines, including oncology, radiology, surgery, and now nuclear medicine, fostering collaboration and knowledge exchange across fields.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI